{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:47:15Z","timestamp":1782283635772,"version":"3.54.5"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), has emerged as a significant public health threat in China. Under the national \u201cphysical and medical integration\u201d framework\u2014which advocates collaborative efforts between healthcare and sports science\u2014there is an urgent need to develop a scientific and practical evaluation system to standardize lifestyle management programs for MASLD patients and support clinical implementation of evidence-based lifestyle interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Building on prior research identifying factors influencing adherence to healthy lifestyles among Chinese MASLD patients, we employed a mixed-methods approach combining in-depth interviews and a two-round Delphi survey with experts from exercise science, public health, health management, exercise prescription for chronic diseases, and hepatology. The Analytic Hierarchy Process (AHP) was used to determine indicator weights and finalize the evaluation framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Six experts participated in in-depth interviews, and 12 experts completed two rounds of Delphi questionnaires (response rates: 100% and 91.7%; authority coefficients: 0.90 and 0.89). The final evaluation system comprises three dimensions: (1) Process evaluation\u20146 first-level indicators (e.g., organizational structure, personnel configuration, supporting facilities) with 12 second-level indicators; (2) Effect evaluation\u20143 first-level indicators (patient participation, lifestyle improvement, follow-up status) with 5 second-level indicators; and (3) Outcome evaluation\u20142 first-level indicators (disease control, health-related physical fitness improvement) with 4 second-level indicators. Kendall's W coefficients indicated statistically significant consensus (first-level: 0.23 and 0.20; second-level: 0.22 and 0.26; all\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). AHP-derived weights were 0.50 for process, 0.25 for effect, and 0.25 for outcome. All consistency ratios (CR) were below 0.1, confirming the validity of the weighting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study successfully developed a multidimensional, reliable, and practice-oriented evaluation system for lifestyle management of MASLD patients under the integration of medicine and physical activity framework. The system provides a standardized tool to assess and improve the quality of integrated lifestyle interventions in clinical settings, offering actionable guidance for delivering coordinated, patient-centered care for MASLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1877424","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:55:39Z","timestamp":1782280539000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of an evaluation framework for a lifestyle management model among Chinese MASLD patients under the concept of physical and medical integration"],"prefix":"10.3389","volume":"14","author":[{"given":"Wenjing","family":"Yan","sequence":"first","affiliation":[{"name":"School of Physical Education, Shanxi Normal University, Taiyuan","place":["Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Competitive Sports, Beijing College of Sports","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Handan First Hospital, Handan","place":["Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan","place":["Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.07.045","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"100099","DOI":"10.1016\/j.jhepr.2020.100099","article-title":"Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis","volume":"2","author":"McSweeney","year":"2020","journal-title":"JHEP Rep."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-25991-0","article-title":"Breaking boundaries: integration of sports and medicine in the community elderly service model","author":"Chen","year":"2025","journal-title":"BMC Public Health."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.3390\/ijerph20032079","article-title":"Policy analysis of the integration of sports and medicine against the backdrop of \u201cHealthy China\u201d: a qualitative study using NVivo","volume":"20","author":"Baihui","year":"2023","journal-title":"Int J Environ Res Public Health."},{"key":"B10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jhep.2016.05.026","article-title":"Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver","volume":"65","author":"Sung KC Ryu","year":"2016","journal-title":"J Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jhepr.2019.10.008","article-title":"Lifestyle modification in NAFLD\/NASH: facts and figures","volume":"1","author":"Hallsworth","year":"2019","journal-title":"JHEP Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/hep.22940","article-title":"Independent effects of physical activity in patients with nonalcoholic fatty liver disease","volume":"50","author":"St George","year":"2009","journal-title":"Hepatology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jhep.2019.08.027","article-title":"A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe","volume":"72","author":"Lazarus","year":"2020","journal-title":"J Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15942\/j.jcsu.2021.05.010","article-title":"Research on the evaluation indicator system for the construction of physical and medical integration demonstration zones","volume":"47","author":"Xueli","year":"2021","journal-title":"J Chengdu Sport Univ."},{"key":"B15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.14036\/j.cnki.cn11-4513.2021.05.002","article-title":"Construction of a physical and medical integration service framework in China under the context of proactive health","volume":"33","author":"Xiaohong","year":"2021","journal-title":"J Cap Univ Phys Educ Sports."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13049-020-0700-9","article-title":"Developing a tool for measuring the disaster resilience of healthcare rescuers: a modified Delphi study","volume":"28","author":"Mao","year":"2020","journal-title":"Scand J Trauma Resusc Emerg Med."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00457","article-title":"Delphi technique in health sciences: a map","author":"Niederberger","year":"2020","journal-title":"Front Public Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.3390\/ijerph19074141","article-title":"Expert consensus on a proposed study framework to explore factors influencing Plasmodium knowlesi malaria preventive behavior: a modified delphi method protocol","volume":"19","author":"Naserrudin","year":"2022","journal-title":"Int J Environ Res Public Health."},{"key":"B19","first-page":"98","article-title":"Research on the construction of a service standard system for physical and medical integration","volume":"5","author":"Chunyan","year":"2019","journal-title":"Stand Sci."},{"key":"B20","first-page":"9","article-title":"Core elements and evolutionary characteristics of the theoretical framework for integrated health care systems: a systematic review","volume":"15","author":"Jia","year":"2022","journal-title":"Chin J Health Policy."},{"key":"B21","volume-title":"Construction and Application of an Evaluation Indicator System for Health Management Service Effectiveness","author":"Xudong","year":"2017"},{"key":"B22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia."},{"key":"B24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.488","article-title":"Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease","author":"Kistler","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41575-021-00477-7","article-title":"Defining comprehensive models of care for NAFLD","volume":"18","author":"Lazarus","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/EJE-20-0065","article-title":"Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease","volume":"183","author":"Ruissen","year":"2020","journal-title":"Eur J Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3238\/arztebl.2014.0453","article-title":"Disease management programs for type 2 diabetes in Germany: a systematic literature review evaluating effectiveness","volume":"111","author":"Fuchs","year":"2014","journal-title":"Dtsch Arztebl Int."},{"key":"B30","volume-title":"WHO package of essential noncommunicable (PEN) disease interventions for primary health care.","year":"2020"},{"key":"B31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/flgastro-2013-100404","article-title":"Non-alcoholic fatty liver disease: a practical approach to treatment","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1877424\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:55:42Z","timestamp":1782280542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1877424\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":31,"alternative-id":["10.3389\/fpubh.2026.1877424"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1877424","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"1877424"}}